Overexpression of carbonic anhydrase and HIF-1α in Wilms tumours

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Dungwa, Josiah V ^a,b   Hunt, Linda P ^b   Ramani, Pramila ^a,b  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONATE DEHYDRATASE; CD31 ANTIGEN; GLUCOSE TRANSPORTER; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; RNA; VASCULOTROPIN; CA9 PROTEIN, HUMAN; GLUCOSE TRANSPORTER 1; ISOPROTEIN; SLC2A1 PROTEIN, HUMAN; TUMOR ANTIGEN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; IMMUNOREACTIVITY; METASTASIS; NEPHRECTOMY; NEPHROBLASTOMA; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA SPLICING; BIOSYNTHESIS; CASE CONTROL STUDY; CHEMISTRY; CHI SQUARE DISTRIBUTION; ENZYMOLOGY; GENETICS; KIDNEY; METABOLISM;

ANTIGENS, NEOPLASM; CARBONIC ANHYDRASES; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUCOSE TRANSPORTER TYPE 1; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; KIDNEY; PROTEIN ISOFORMS; REAL-TIME POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WILMS TUMOR;

EID: 80052607424     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-390     Document Type: Article

References (39)

1. Semenza GL. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 2010, 29:625-634. 10.1038/onc.2009.441, 2969168, 19946328.
2. Chiche J, Ilc K, Laferriere J, Trottier E, Dayan F, Mazure NM, Brahimi-Horn MC, Pouyssegur J. Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH. Cancer Res 2009, 69:358-368. 10.1158/0008-5472.CAN-08-2470, 19118021.
3. Robertson N, Potter C, Harris AL. Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion. Cancer Res 2004, 64:6160-6165. 10.1158/0008-5472.CAN-03-2224, 15342400.
4. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003, 3:721-732. 10.1038/nrc1187, 13130303.
5. Parkkila S. Significance of pH regulation and carbonic anhydrases in tumour progression and implications for diagnostic and therapeutic approaches. BJU Int 2008, 101(Suppl 4):16-21.
6. Scotting PJ, Walker DA, Perilongo G. Childhood solid tumours: a developmental disorder. Nat Rev Cancer 2005, 5:481-488. 10.1038/nrc1633, 15905853.
7. Karth J, Ferrer FA, Perlman E, Hanrahan C, Simons JW, Gearhart JP, Rodriguez R. Coexpression of hypoxia-inducible factor 1-alpha and vascular endothelial growth factor in Wilms' tumor. J Pediatr Surg 2000, 35:1749-1753. 10.1053/jpsu.2000.19241, 11101729.
8. Wittmann S, Wunder C, Zirn B, Furtwangler R, Wegert J, Graf N, Gessler M. New prognostic markers revealed by evaluation of genes correlated with clinical parameters in Wilms tumors. Genes Chromosomes Cancer 2008, 47:386-395. 10.1002/gcc.20544, 18260125.
9. Barathova M, Takacova M, Holotnakova T, Gibadulinova A, Ohradanova A, Zatovicova M, Hulikova A, Kopacek J, Parkkila S, Supuran CT, Pastorekova S, Pastorek J. Alternative splicing variant of the hypoxia marker carbonic anhydrase IX expressed independently of hypoxia and tumour phenotype. Br J Cancer 2008, 98:129-136. 10.1038/sj.bjc.6604111, 2359689, 18026188.
10. Malentacchi F, Simi L, Nannelli C, Andreani M, Janni A, Pastorekova S, Orlando C. Alternative splicing variants of carbonic anhydrase IX in human non-small cell lung cancer. Lung Cancer 2009, 64:271-276. 10.1016/j.lungcan.2008.10.001, 19022520.
11. Oosterwijk E. Carbonic anhydrase IX: historical and future perspectives. BJU Int 2008, 101(Suppl 4):2-7.
12. Pastorekova S, Zatovicova M, Pastorek J. Cancer-associated carbonic anhydrases and their inhibition. Curr Pharm Des 2008, 14:685-698. 10.2174/138161208783877893, 18336315.
13. Rivera MN, Haber DA. Wilms' tumour: connecting tumorigenesis and organ development in the kidney. Nat Rev Cancer 2005, 5:699-712. 10.1038/nrc1696, 16110318.
14. Kaste SC, Dome JS, Babyn PS, Graf NM, Grundy P, Godzinski J, Levitt GA, Jenkinson H. Wilms tumour: prognostic factors, staging, therapy and late effects. Pediatr Radiol 2008, 38:2-17. 10.1007/s00247-007-0687-7, 18026723.
15. Sobhanifar S, Aquino-Parsons C, Stanbridge EJ, Olive P. Reduced expression of hypoxia-inducible factor-1 alpha in perinecrotic regions of solid tumors. Cancer Res 2005, 65:7259-7266. 10.1158/0008-5472.CAN-04-4480, 16103077.
16. Beasley NJ, Wykoff CC, Watson PH, Leek R, Turley H, Gatter K, Pastorek J, Cox GJ, Ratcliffe P, Harris AL. Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density. Cancer Res 2001, 61:5262-5267.
17. Jubb AM, Buffa FM, Harris AL. Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis. J Cell Mol Med 2010, 14:18-29. 10.1111/j.1582-4934.2009.00944.x, 19840191.
18. Vleugel MM, Greijer AE, Shvarts A, van der GP, van BM, Aarbodem Y, van TH, Harris AL, van Diest PJ, van der WE. Differential prognostic impact of hypoxia induced and diffuse HIF-1 alpha expression in invasive breast cancer. J Clin Pathol 2005, 58:172-177. 10.1136/jcp.2004.019885, 1770566, 15677538.
19. Wykoff CC, Beasley NJ, Watson PH, Turner KJ, Pastorek J, Sibtain A, Wilson GD, Turley H, Talks KL, Maxwell PH, Pugh CW, Ratcliffe PJ, Harris AL. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 2000, 60:7075-7083.
20. Poon E, Harris AL, Ashcroft M. Targeting the hypoxia-inducible factor (HIF) pathway in cancer. Expert Rev Mol Med 2009, 11:e26.
21. Hedley D, Pintilie M, Woo J, Morrison A, Birle D, Fyles A, Milosevic M, Hill R. Carbonic anhydrase IX expression, hypoxia, and prognosis in patients with uterine cervical carcinomas. Clin Cancer Res 2003, 9:5666-5674.
22. Iakovlev VV, Pintilie M, Morrison A, Fyles AW, Hill RP, Hedley DW. Effect of distributional heterogeneity on the analysis of tumor hypoxia based on carbonic anhydrase IX. Lab Invest 2007, 87:1206-1217. 10.1038/labinvest.3700680, 17906661.
23. Poomthavorn P, Wong SH, Higgins S, Werther GA, Russo VC. Activation of a prometastatic gene expression program in hypoxic neuroblastoma cells. Endocr Relat Cancer 2009, 16:991-1004. 10.1677/ERC-08-0340, 19423615.
24. Zavada J, Zavadova Z, Pastorek J, Biesova Z, Jezek J, Velek J. Human tumour-associated cell adhesion protein MN/CA IX: identification of M75 epitope and of the region mediating cell adhesion. Br J Cancer 2000, 82:1808-1813. 10.1054/bjoc.2000.1111, 2363230, 10839295.
25. Zavadova Z, Zavada J. Carbonic anhydrase IX (CA IX) mediates tumor cell interactions with microenvironment. Oncol Rep 2005, 13:977-982.
26. Svastova E, Zilka N, Zat'ovicova M, Gibadulinova A, Ciampor F, Pastorek J, Pastorekova S. Carbonic anhydrase IX reduces E-cadherin-mediated adhesion of MDCK cells via interaction with beta-catenin. Exp Cell Res 2003, 290:332-345. 10.1016/S0014-4827(03)00351-3, 14567991.
27. Alami J, Williams BR, Yeger H. Differential expression of E-cadherin and beta catenin in primary and metastatic Wilms's tumours. Mol Pathol 2003, 56:218-225. 10.1136/mp.56.4.218, 1187324, 12890743.
28. Baudry D, Cabanis MO, Patte C, Zucker JM, Pein F, Fournet JC, Sarnacki S, Junien C, Jeanpierre C. Cadherins in Wilms' tumor: E-cadherin expression despite absence of WT1. Anticancer Res 2003, 23:475-478.
29. Schulz S, Becker KF, Braungart E, Reichmuth C, Klamt B, Becker I, Atkinson M, Gessler M, Hofler H. Molecular analysis of E-cadherin and cadherin-11 in Wilms' tumours. J Pathol 2000, 191:162-169. 10.1002/(SICI)1096-9896(200006)191:2<162::AID-PATH604>3.0.CO;2-8, 10861576.
30. Safford SD, Freemerman AJ, Langdon S, Bentley R, Goyeau D, Grundy PE, Skinner MA. Decreased E-cadherin expression correlates with higher stage of Wilms' tumors. J Pediatr Surg 2005, 40:341-348. 10.1016/j.jpedsurg.2004.10.030, 15750927.
31. Swinson DE, Jones JL, Richardson D, Wykoff C, Turley H, Pastorek J, Taub N, Harris AL, O'Byrne KJ. Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer. J Clin Oncol 2003, 21:473-482. 10.1200/JCO.2003.11.132, 12560438.
32. Ivanov S, Liao SY, Ivanova A, nilkovitch-Miagkova A, Tarasova N, Weirich G, Merrill MJ, Proescholdt MA, Oldfield EH, Lee J, Zavada J, Waheed A, Sly W, Lerman MI, Stanbridge EJ. Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. Am J Pathol 2001, 158:905-919. 10.1016/S0002-9440(10)64038-2, 1850340, 11238039.
33. Liao SY, Lerman MI, Stanbridge EJ. Expression of transmembrane carbonic anhydrases, CAIX and CAXII, in human development. BMC Dev Biol 2009, 9(22):1-16. 2648952, 19126199.
34. Rafajova M, Zatovicova M, Kettmann R, Pastorek J, Pastorekova S. Induction by hypoxia combined with low glucose or low bicarbonate and high posttranslational stability upon reoxygenation contribute to carbonic anhydrase IX expression in cancer cells. Int J Oncol 2004, 24:995-1004.
35. Kaluz S, Kaluzova M, Chrastina A, Olive PL, Pastorekova S, Pastorek J, Lerman MI, Stanbridge EJ. Lowered oxygen tension induces expression of the hypoxia marker MN/carbonic anhydrase IX in the absence of hypoxia-inducible factor 1 alpha stabilization: a role for phosphatidylinositol 3'-kinase. Cancer Res 2002, 62:4469-4477.
36. Ihnatko R, Kubes M, Takacova M, Sedlakova O, Sedlak J, Pastorek J, Kopacek J, Pastorekova S. Extracellular acidosis elevates carbonic anhydrase IX in human glioblastoma cells via transcriptional modulation that does not depend on hypoxia. Int J Oncol 2006, 29:1025-1033.
37. Wetli SC, Leuschner I, Harms D, Rufle A, Foerster A, Bihl M, Graf N, Furtwaengler R, Paulussen M, Briner J, Aslanidis C, Schmitz G, Tornillo L, Mihatsch MJ, Zlobec I, Bruder E. KIT, PDGFRalpha and EGFR analysis in nephroblastoma. Virchows Arch 2008, 452:637-650. 10.1007/s00428-008-0605-x, 18478259.
38. Vasei M, Modjtahedi H, le-Booyeh O, Mosallaei A, Kajbafzadeh AM, Shahriari M, Ghaderi AA, Soleymanpour H, Kosari F, Moch H, Sauter G. Amplification and expression of EGFR and ERBB2 in Wilms tumor. Cancer Genet Cytogenet 2009, 194:88-95. 10.1016/j.cancergencyto.2009.06.003, 19781441.
39. Ghanem MA, van der Kwast TH, Den Hollander JC, Sudaryo MK, Mathoera RB, Van den Heuvel MM, Noordzij MA, Nijman RJ, van Steenbrugge GJ. Expression and prognostic value of epidermal growth factor receptor, transforming growth factor-alpha, and c-erb B-2 in nephroblastoma. Cancer 2001, 92:3120-3129. 10.1002/1097-0142(20011215)92:12<3120::AID-CNCR10173>3.0.CO;2-2, 11753991.